[go: up one dir, main page]

AU2002328630A1 - Method of diagnosing or monitoring saccharometabolic error - Google Patents

Method of diagnosing or monitoring saccharometabolic error

Info

Publication number
AU2002328630A1
AU2002328630A1 AU2002328630A AU2002328630A AU2002328630A1 AU 2002328630 A1 AU2002328630 A1 AU 2002328630A1 AU 2002328630 A AU2002328630 A AU 2002328630A AU 2002328630 A AU2002328630 A AU 2002328630A AU 2002328630 A1 AU2002328630 A1 AU 2002328630A1
Authority
AU
Australia
Prior art keywords
saccharometabolic
diagnosing
error
monitoring
saccharometabolic error
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002328630A
Other versions
AU2002328630B2 (en
Inventor
Hiroshi Hirose
Koichi Matsubara
Yasuko Nakano
Motowo Tomita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Priority claimed from PCT/JP2002/008331 external-priority patent/WO2003016906A1/en
Publication of AU2002328630A1 publication Critical patent/AU2002328630A1/en
Application granted granted Critical
Publication of AU2002328630B2 publication Critical patent/AU2002328630B2/en
Assigned to FUJIREBIO, INC. reassignment FUJIREBIO, INC. Alteration of Name(s) in Register under S187 Assignors: REBIO GEN, INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002328630A 2001-08-17 2002-08-16 Method of diagnosing or monitoring saccharometabolic error Ceased AU2002328630B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001248047 2001-08-17
JP2001-248047 2001-08-17
PCT/JP2002/008331 WO2003016906A1 (en) 2001-08-17 2002-08-16 Method of diagnosing or monitoring saccharometabolic error

Publications (2)

Publication Number Publication Date
AU2002328630A1 true AU2002328630A1 (en) 2003-05-29
AU2002328630B2 AU2002328630B2 (en) 2005-09-01

Family

ID=19077272

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002328630A Ceased AU2002328630B2 (en) 2001-08-17 2002-08-16 Method of diagnosing or monitoring saccharometabolic error

Country Status (10)

Country Link
US (2) US7067634B2 (en)
EP (1) EP1426764B1 (en)
JP (1) JP3624216B2 (en)
AT (1) ATE504001T1 (en)
AU (1) AU2002328630B2 (en)
CA (1) CA2459489C (en)
DE (1) DE60239622D1 (en)
DK (1) DK1426764T3 (en)
ES (1) ES2361663T3 (en)
WO (1) WO2003016906A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1607742E (en) 2003-03-24 2012-01-19 Otsuka Pharma Co Ltd Latex reagent for adiponectin analysis and method of adiponectin analysis
WO2004096272A2 (en) * 2003-04-29 2004-11-11 Cytos Biotechnology Ag Methods and compositions for modulating the interaction between adiponectin and its receptor
WO2005094200A2 (en) * 2003-06-20 2005-10-13 University Of Florida Biomarkers for differentiating between type 2 and type 2 diabetes
US7176292B2 (en) * 2003-09-11 2007-02-13 Dialean, Ltd. Ghrelin variant protein
EP2071333B1 (en) * 2003-10-15 2012-04-18 Sekisui Medical Co., Ltd. Method of selectively assaying adiponectin multimers
US7781171B2 (en) 2003-10-15 2010-08-24 Daiichi Pure Chemicals Co., Ltd. Mehod of pretreating sample and immunological assay method using the same
DE602004022968D1 (en) * 2003-11-07 2009-10-15 Merck & Co Inc IE TREATMENT MTI INSULIN SENSITIZERS
WO2005092367A1 (en) * 2004-03-29 2005-10-06 Fuji Oil Company, Limited Composition for promoting adiponectin secretion
EP1744160B1 (en) * 2004-03-31 2011-07-06 Kazuhisa Maeda Use of adiponectin as marker in the prediction of post-operative infection
US8563581B2 (en) * 2005-02-02 2013-10-22 Mitos Pharmaceuticals, Inc. Nitroxides for use in treating predisposed or at risk patients
GB0617429D0 (en) 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
CA2707182C (en) * 2007-11-30 2017-12-12 Siemens Healthcare Diagnostics Inc. Adiponectin receptor fragments and methods of use
CN102388308B (en) 2009-04-23 2015-08-19 西门子医疗保健诊断公司 Adiponectin receptor fragments in monomeric and dimeric forms and methods of use
JP5824359B2 (en) 2009-05-07 2015-11-25 株式会社Lsiメディエンス Novel monoclonal antibodies and their use for the analysis of macromolecular adiponectin
JP5048100B2 (en) 2010-04-28 2012-10-17 シャープ株式会社 Peptide having binding property to adiponectin, and analysis method and analyzer using the peptide
RU2553943C1 (en) * 2014-05-27 2015-06-20 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО МГМУ им. И.М. Сеченова) Diagnostic technique for insulin resistance
AU2020223826A1 (en) * 2019-02-18 2021-08-05 The University Of Liverpool Method of diagnosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE98950411T1 (en) 1997-10-29 2005-10-20 Otsuka Pharma Co Ltd A composition for inhibiting smooth muscle proliferation, methods for diagnosing arteriosclerosis, and kits therefor
WO2001032868A1 (en) * 1999-11-04 2001-05-10 Genset Apm1 biallelic markers and uses thereof

Similar Documents

Publication Publication Date Title
AU2002360634A1 (en) System for monitoring physiological characteristics
AU2002328630A1 (en) Method of diagnosing or monitoring saccharometabolic error
AU2002367180A1 (en) Concentration measuring method
EP1434989B8 (en) Method and apparatus for diagnosing hemostasis
AU2002352446A1 (en) System and method for monitoring usage patterns
AU2003283235A1 (en) Method for monitoring sensor function
GB0106817D0 (en) Monitoring method
AU2002324228A1 (en) Health monitoring system
AU2002366398A1 (en) Structural health monitoring
AUPR958601A0 (en) Remote monitoring
AU2002327860A1 (en) Diagnostic methods
EP1376555B8 (en) Offset measuring method
AU2002323855A1 (en) Method for diagnosing the functional condition of an organism
AU2002219357A1 (en) Monitoring system
AU2002307540A1 (en) Method for evaluating personnel
AU2002344611A1 (en) Method of diagnosing type 2 diabetes
AU2002251169A1 (en) Monitoring method
AUPS236502A0 (en) Method of monitoring measurements
AUPR783601A0 (en) Prognostic method
AU2002244989A1 (en) Method of contact monitoring
AUPR417601A0 (en) Method of diagnosing mastitis
AU2002340755A1 (en) Method for monitoring an automation unit
AU2002332832A1 (en) Method of diagnosing nephrotic syndrome
AU2003266059A1 (en) Method of diagnosing osteolysis
HK1064073A (en) Condition monitoring system